Table 1: Patients characteristics.

CharacteristicsNHL patients ( )

 <60 yrs51
 >60 yrs27
Ann Arbor stage
B symptoms
Serum LDH
Performance status (ECOG)
Number of extranodal sites
Serum β2-microglobulin
IPI risk groups
 Low/intermediate low (1, 2)40
 Intermediate high/high (3, 4)38
Histological aggressiveness
  Follicular 17
  Small lymphocytic15
  Other B cells8
  Diffuse large B-cell lymphoma28
  Peripheral T cell3
Response to treatment
 Complete remission 35
 Partial remission30
 No response13

NHL: non-Hodgkin’s lymphoma; LDH: serum lactate dehydrogenase; ECOG: Eastern Cooperative Oncology Group; IPI: International Prognostic Index.
*>480 U/L; >1.80 mg/L.